Growth Metrics

Lifecore Biomedical (LFCR) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$1.27.

  • Lifecore Biomedical's EPS (Weighted Average and Diluted) rose 84.21% to -$0.03 in Q2 2025 from the same period last year, while for May 2025 it was -$1.28, marking a year-over-year decrease of 709.52%. This contributed to the annual value of -$1.27 for FY2025, which is 484.85% down from last year.
  • Per Lifecore Biomedical's latest filing, its EPS (Weighted Average and Diluted) stood at -$1.27 for FY2025, which was down 484.85% from $0.33 recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's EPS (Weighted Average and Diluted) registered a high of $0.33 during FY2024, and its lowest value of -$3.97 during FY2022.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$1.27 (2025), whereas its average is -$1.42.
  • In the last 5 years, Lifecore Biomedical's EPS (Weighted Average and Diluted) soared by 109.94% in 2024 and then tumbled by 484.85% in 2025.
  • Yearly analysis of 5 years shows Lifecore Biomedical's EPS (Weighted Average and Diluted) stood at -$1.10 in 2021, then crashed by 260.91% to -$3.97 in 2022, then climbed by 16.37% to -$3.32 in 2023, then surged by 109.94% to $0.33 in 2024, then slumped by 484.85% to -$1.27 in 2025.